Search

everythinglearnresearchcommunity

for

Search:↓

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

"D-CHRAMPS syndrome" is a newly identified condition with multiple severe symptoms.

AMPK activation may reduce melanoma risk in red-haired individuals.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Adrenomedullin 2 stops cell growth and causes cell death in human hair follicles.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Certain alkaloids could help create new coronavirus drugs.

A patient with congenital adrenal hyperplasia improved after adjusting her medication to prevent Cushing's syndrome symptoms.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.

Cyclohexyl salicylate promotes human hair growth and increases certain hair follicle stem cell progeny.

PTHrP regulates various normal body functions, including bone development, skin, and muscle function.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

5α-Reductase helps regulate hormone action in toad testes, especially during breeding season.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Certain hormone treatments can improve acne and related conditions in women.